Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors
Kim M. Olthoff(University of Pennsylvania), Jason D. Christie(University of Pennsylvania), Benjamin Samstein(Cornell University), Mary Kaminski(Hospital of the University of Pennsylvania), Abraham Shaked(University of Pennsylvania), Michaël Abécassis(University of Arizona), Laura Kulik(Northwestern University), Jean C. Emond(Columbia University Irving Medical Center)
Cited by 1,247
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
The International Position on Laparoscopic Liver Surgery
|Annals of Surgery|2009|1.5k
Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes
|Gastroenterology|2009|1.1k
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter
|American Journal of Transplantation|2020|837